How will legal challenges fare against CMS rule on gender-affirming care?
A CMS rule finalized this week may prove more difficult to challenge than previous Trump administration actions to end transgender care for young people.
The Trump administration's push to eliminate transgender healthcare for minors has encountered numerous legal obstacles. However, a recent Centers for Medicare and Medicaid Services (CMS) rule could pose a greater challenge to challenge. The agency's decision announced on Tuesday to prevent the use of federal Medicaid and Children's Health Insurance Program (CHIP) funds for pediatric gender-affirming medications and surgery is proving to be more formidable to contest.
On Thursday, the Department of Health and Human Services (HHS) released a report on diagnostic coding practices among gender-affirming care providers. The report has led to the referral of hundreds of healthcare groups to the Justice Department for investigation into their practices. Despite experiencing multiple court defeats, the administration has managed to coerce numerous hospitals into either closing or pausing their gender-affirming care programs.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
